Related Experiment Video

Updated: Jul 2, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease

Marcus J Calkins1, Delinda A Johnson, Jessica A Townsend

  • 1Molecular and Environmental Toxicology Center, University of Wisconsin, Madison, Wisconsin 53705, USA.

Antioxidants & Redox Signaling
|August 23, 2008
PubMed

Insights

Nuclear factor E2-related factor 2 (Nrf2) shows potential for neuroprotection against oxidative stress in neurodegenerative diseases. Targeting Nrf2 may offer a therapeutic strategy for conditions involving free radical damage and mitochondrial dysfunction.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Nuclear factor E2-related factor 2 (Nrf2) is a key transcription factor regulating cytoprotective and detoxification genes.
  • Nrf2-regulated genes are implicated in protecting against neurodegenerative conditions.
  • Oxidative stress and mitochondrial dysfunction are common mechanisms in neurodegeneration.

Purpose of the Study:

  • To review the literature on Nrf2's role in neuroprotection.
  • To explore Nrf2 as a therapeutic target for neurodegenerative diseases.
  • To illustrate potential mechanisms of Nrf2-mediated neuroprotection.

Main Methods:

  • Literature review of laboratory models and experimental studies.
  • Analysis of Nrf2-mediated gene expression.
  • Investigation of Nrf2's involvement in oxidative stress pathways.

Main Results:

  • Nrf2 activation demonstrates protective effects against neurodegeneration in laboratory models.
  • Nrf2 targets genes involved in combating oxidative stress and mitochondrial dysfunction.
  • Evidence suggests Nrf2-mediated transcription can mitigate neurodegeneration.

Conclusions:

  • Nrf2 is a promising therapeutic target for neurodegenerative diseases.
  • Targeting Nrf2 may offer a strategy for conditions with diverse etiologies involving oxidative stress.
  • Further research in laboratory models is crucial to validate Nrf2's neuroprotective potential.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes: